Completed
LINX: Discontinuation of PPI Use
Class Central Classrooms beta
YouTube videos curated by Class Central.
Classroom Contents
New Options for Treating GERD – Beyond PPIs - David C. Chen, MD - UCLA Digestive Disease
Automatically move to the next video in the Classroom when playback concludes
- 1 Intro
- 2 Gastroesophageal Reflux: Treatment
- 3 Gastroesophageal Reflux: Limitations of PPIS
- 4 Indications for Surgery: Gastointestinal Indications
- 5 Goals of Interventional Therapy
- 6 Gastroesophageal Reflux: Alternatives
- 7 The Treatment Gap
- 8 Gastroesophageal Reflux: Endoscopic Therapies
- 9 Endoscopic Therapies: Commercially Available
- 10 Transoral Incisionless Fundoplication: Esophyx
- 11 Radiofrequency Ablation: Stretta
- 12 Endoscopic Therapies: Currently Being Studied
- 13 Endoscopic Stapling System: MediGus SRS
- 14 Endoscopic Therapies: No Longer Available
- 15 Gastroesophageal Reflux: Surgical Options
- 16 Surgical Options: Nissen Fundoplication
- 17 Surgical Options: Toupet Fundoplication
- 18 Fundoplication Versus Medical Management
- 19 Surgical Options: LINX Magnetic Sphincter Augmentation FDA PMA approved March 2012
- 20 Mechanism of Action
- 21 LINX: Overview
- 22 LINX: Reduction in Esophageal Acid Exposure
- 23 LINX: Discontinuation of PPI Use
- 24 LINX: Patient Satisfaction
- 25 LINX: Side Effects
- 26 LINX: Treatment Efficacy
